Columbia University Irving Medical Center
New York, United States
Andrew B. Lassman is the John Harris Associate Professor of Neurology and the Chief of Neuro-Oncology at Columbia University. After earning BS and MS degrees in Molecular Biophysics and Biochemistry at Yale, he received his MD from the Columbia University Vagelos College of Physicians & Surgeons, subsequently completed Neurology residency at the Neurological Institute of NewYork-Presbyterian Hospital/Columbia University Irving Medical Center (CUIMC). In 2001 he began fellowship in Neuro-Oncology at Memorial Sloan Kettering Cancer Center, where he then joined the faculty and served as fellowship director.
In November 2011, Dr. Lassman returned to CUIMC as Neuro-Oncology Chief and also is Medical Director for the Clinical Protocol Data Management Office of the Herbert Irving Comprehensive Cancer Center, a centralized department which supports execution of pilot through phase 3 therapeutic clinical trials as well as cancer prevention and control studies for all cancers at CUIMC.
His research and clinical efforts focus on improving the understanding and treatment of brain tumors. He has led retrospective studies, single institution prospective clinical trials, and multicenter prospective trials. All of these projects have molecular correlative analyses as an important scientific aim to understand the reasons for treatment success or failure, and to refine treatment paradigms.